Three scientists -- Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) -- were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares end up 0.69%
03/18/2025 01:54 PM - Business
TSMC shares return to prior ex-dividend level upon opening
03/18/2025 12:09 PM - Business
Furloughed workers fall below 2,000 as manufacturing sector improves
03/18/2025 11:34 AM - Society
Taiwan's highest mountains get snow from latest cold front
03/18/2025 11:20 AM - Business
U.S. dollar lower in Taipei trading
03/18/2025 11:16 AM